TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Developer of tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Developer of tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.
Citryll was established in 2015 and is headquartered in Oss, The Netherlands.